Roger Adsett

Roger Adsett

Chief Operating Officer at INSMED INCORPORATED

Net worth: 10 M $ as of 2024-06-29

55 year
100 connections
Health Technology
Consumer Services
Finance

Roger Adsett active positions

CompaniesPositionStartEnd
INSMED INCORPORATED Chief Operating Officer 2019-11-13 -
Corporate Officer/Principal 2016-09-26 2019-11-13

Career history of Roger Adsett

Former positions of Roger Adsett

CompaniesPositionStartEnd
LANDOS BIOPHARMA, INC. Director/Board Member 2022-03-07 2024-05-22
Independent Dir/Board Member 2022-03-07 2024-05-22
SHIRE Corporate Officer/Principal 2005-09-30 2016-08-31
ASTRAZENECA PLC Sales & Marketing 1994-10-31 2005-09-30
Nexium, Inc. Sales & Marketing - -
AstraZeneca R & D Lund Sales & Marketing - -

Training of Roger Adsett

The Wharton School of the University of Pennsylvania Masters Business Admin
Bucknell University Undergraduate Degree

Statistics

International

United States 6
Ireland 2
Sweden 2

Operational

Sales & Marketing 3
Corporate Officer/Principal 2
Chief Operating Officer 1

Sectoral

Health Technology 5
Consumer Services 3
Finance 2

Positions held

Active

Inactive

Listed companies

Private companies

Linked companies

Listed companies3
INSMED INCORPORATED

Health Technology

ASTRAZENECA PLC

Health Technology

LANDOS BIOPHARMA, INC.

Health Technology

Private companies3
Shire Plc
Logo Shire Plc

Shire Plc

Pharmaceuticals: MajorHealth Technology

Shire Plc is a biopharmaceutical company, which engages in the research, development, licensing, manufacturing, marketing, distribution, and sale of medicines. Its products include adderall, advate, adynovate, agrylin, antithrombin 3, aralast, bebulin, buccolam, feiba, firazyr, and foznol. The company was founded in 1986 and is headquartered in Dublin, Ireland.

Health Technology

AstraZeneca R & D Lund

Nexium, Inc.

Finance

See company connections
  1. Stock Market
  2. Insiders
  3. Roger Adsett
  4. Experience